According to Arvinas's latest financial reports the company's current revenue (TTM) is $78.5 M. In 2022 the company made a revenue of $0.13 B an increase over the years 2021 revenue that were of $46.63 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $78.5 M | -43.57% |
2022 | $0.13 B | 198.3% |
2021 | $46.63 M | 113.89% |
2020 | $21.8 M | -49.27% |
2019 | $42.97 M | 200.03% |
2018 | $14.32 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |